Neocis Gen 2 Anterior Chairside Splint Mislabeling Recall
Neocis recalls Gen 2 Anterior Chairside Splints due to possible mislabeling. Affected units may not be correctly identified, but no safety risk is reported.
Lower-risk recall
The LRUL and LLUR posterior chairside splints and the LLUR anterior chairside splints may be mislabeled.
Contact the company
What happened, in plain English
Neocis is recalling Gen 2 Anterior Chairside Splints that may be mislabeled. This could lead to incorrect identification of the product, but there is no stated safety risk. Read more at govinfonow.com/recall/64027-neocis-gen-2-anterior-chairside-splint-mislabeling-recall.
Source Summary by GovInfoNow · govinfonow.com/recall/64027-neocis-gen-2-anterior-chairside-splint-mislabeling-recall · Updated August 19, 2026 · FDA enforcement record: FDA #Z-0929-2021
Cite this page
“Neocis Gen 2 Anterior Chairside Splint Mislabeling Recall.” GovInfoNow, updated August 19, 2026. https://govinfonow.com/recall/64027-neocis-gen-2-anterior-chairside-splint-mislabeling-recall. Based on FDA recall #Z-0929-2021 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-0929-2021%22&limit=1).
Why it’s dangerous
The splints may be mislabeled, meaning they could be incorrectly identified. This could lead to confusion about which splint is being used, but the recall does not indicate any safety hazard.
Who’s affected
Dentists and dental clinics using Neocis Gen 2 Anterior Chairside Splints. Patients using these splints are at minimal risk if the mislabeling does not affect product function.
How to tell if you have this one
Check for the model number DRW-073:Gen 2 Anterior Chairside Splint LRUL (lower right-upper left) on the product. The recall covers accessories to the Neocis Guidance System (NGS) with Work Order (Lot) Number 1573.
- Brand
Neocis- Category
Medical device
What to do — step by step
Check Product Label
Look for the model number DRW-073:Gen 2 Anterior Chairside Splint LRUL (lower right-upper left) on the product.
Where it went and when
Where it was distributed
Distributed in 7 states.
FDA distribution: “OH, FL, CT, MA, AZ PA, NY” States read from FDA’s own wording; “not listed” means the notice does not name it.
States: Arizona, Connecticut, Florida, Massachusetts, New York, Ohio, Pennsylvania.
Recall timeline
FDA terminated this recall 9 months after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest medical device recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #Z-0929-2021 (October 30, 2020) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-0929-2021 to see it in context.
- Plain-language summary written by qwen3:4b on August 19, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.